Sexual dysfunction in the older woman: An overview of the current understanding and management

Drugs and Aging

Volumn 21, Issue 10, 2004, Pages 655-675

  Walsh, Kathleen E ^a,b   Berman, Jennifer R ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Monroe Clinic   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BUSULFAN; BUTYROPHENONE; CARBAMAZEPINE; CHLORAMBUCIL; CIMETIDINE; CLONIDINE; CYCLOPHOSPHAMIDE; DILTIAZEM; DIPHENHYDRAMINE; HYDROCHLOROTHIAZIDE; METOPROLOL; MONOAMINE OXIDASE INHIBITOR; NIFEDIPINE; OPIATE DERIVATIVE; ORAL CONTRACEPTIVE AGENT; OXYCODONE; PHENOBARBITAL; PHENOTHIAZINE; PHENYTOIN; PRAZOSIN; PROPRANOLOL; RALOXIFENE; RESERPINE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SPIRONOLACTONE; TAMOXIFEN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AGING; ELECTROSTIMULATION; FEMALE; FEMALE SEXUAL DYSFUNCTION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPERTENSION; LIBIDO; LIBIDO DISORDER; MENTAL DISEASE; NEUROLOGIC DISEASE; ORGASM DISORDER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHOGENESIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; VASCULAR DISEASE;

AGING; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DRUG THERAPY; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; WOMEN'S HEALTH;

EID: 4344648263     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200421100-00004     Document Type: Review

References (126)

1. Bortz II WM, Wallace DH. Physical fitness, aging, and sexuality. West J Med 1999 Mar; 170 (3): 167-9
2. Gelfand MM. Secuality among older women. J Womens Health Gend Based Med 2000; 9 Suppl. 1: S15-20
3. Matthias RE, Lubben JE, Atchison KA. Sexual activity and satisfaction among very old adults: results from a community-dwelling medicare population survey. Gerontologist 1997; 37: 6-14
4. US Bureau of the Census. Projections of the population of the United States: 1977 to 2050. In: Current population reports. Washington, DC: Government Printing Office 1995: P25-704
5. US Bureau of the Census. Current population reports, special studies: 65+ in the United States. Washington, DC: Government Printing Office, 1996: P23-190
6. Kinsey AC, Pomeroy WB, Martin CE. Sexual behavior in the human male. Philadelphia (PA): WB Saunders, 1953
7. Masters WH, Johnson VE. Human sexual response. Boston (MA): Little, Brown and Company, 1966
8. Pfeiffer E, Verwoerdt A, Wang HS. Sexual behavior in aged men and women. Arch Gen Psychiatry 1968; 19: 735-58
9. Christenson CV, Gagnon JH. Sexual behavior in a group of older women. J Gerontol 1965; 20: 351-6
10. George LK, Weiler SJ. Sexuality in middle and late life. Arch Gen Psychiatry 1981; 38: 919-23
11. Bretschneider JG, McCoy NL. Sexual interest and behavior in healthy 80 to 102 year olds. Arch Sex Behav 1988; 17: 109-29
12. Janus SS, Janus CL. The Janus report on sexual behavior. New York: John Wiley & Sons, 1993
13. Starr BD, Weiner MB. The Starr-Weiner report on sex and sexuality in mature years. Briarcliff Manor (NY): Stein and Day, 1981
14. Diokno AC, Brown MB, Herzog AR. Sexual function in the elderly. Arch Intern Med 1990; 150: 197-200
15. Marsiglio W, Donnelly D. Sexual relations in later life: a national study of married persons. J Gerontol 1991; 46: S338-344
16. Croft LH. Sexuality in later life: a counseling guide for physicians. Boston (MA): John Wright-PSG, 1982
17. Mooradian AD, Greiff V. Sexuality in older women. Ach Intern Med 1990; 150: 1033-8
18. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537-44
19. Sarrel PM, Whitehead MI. Sex and menopause: defining the issues. Maturitas 1985 Sep; 7 (3): 217-24
20. Rosen RC, Taylor JF, Leiblum SR, et al. Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Marital Ther 1993; 19: 171-88
21. Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990 Apr; 75 (4 Suppl.): 26-S30
22. Basson R, Berman J, Burnett A, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000; 183: 888-93
23. Bachmann GA, Leiblum SR. The impact of hormones on menopausal sexuality: a literature review. Menopause 2004 Jan-Feb; 11 (1): 120-30
24. Warnock JK, Bundren JC, Morris DW. Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues. Psychopharmacol Bull 1997; 33 (4): 761-6
25. Segraves RT. Female sexual disorders: psychiatric aspects. Can J Psychiatry 2002 Jun; 47 (5): 419-25
26. Impett EA, Peplau LA. Sexual compliance: gender, motivational, and relationship perspectives. J Sex Res 2003 Feb; 40 (1): 87-100
27. Basson R. A model of women's sexual arousal. J Sex Marital Ther 2002 Jan-Feb; 28 (1): 1-10
28. Barton D, Joubert L. Psychosocial aspects of sexual disorders. Aust Fam Physician 2000 Jun; 29 (6): 527-31
29. Mah K, Binik YM. The nature of human orgasm: a critical review of major trends. Clin Psychol Rev 2001 Aug; 21 (6): 823-56
30. Goodlin RC. Orgasm is the thing! Am J Obstet Gynecol 1994 Jul; 171 (1): 282-3
31. Pierce AP. The coital alignment technique (CAT): an overview of studies. J Sex Marital Ther 2000 Jul-Sep; 26 (3): 257-68
32. Mah K, Binik YM. Do all orgasms feel alike? Evaluating a two-dimensional model of the orgasm experience across gender and sexual context. J Sex Res 2002 May; 39 (2): 104-13
33. Kelly MP, Strassberg DS, Kircher JR. Attitudinal and experiential correlates of anorgasmia. Arch Sex Behav 1990 Apr; 19 (2): 165-77
34. Pauls RN, Berman JR. Impact of pelvic floor disorders and prolapse on female sexual function and response. Urol Clin North Am 2002 Aug; 29 (3): 677-83
35. Salonia A, Zanni G, Nappi RE, et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Eur Urol 2004 May; 45 (5): 642-8
36. Bidmead J, Cardozo LD. Pelvic floor changes in the older woman. Br J Urol 1998 Dec; 82 Suppl. 1: 18-25
37. Graziottin A. Etiology and diagnosis of coital pain. J Endocrinol Invest 2003; 26 (3 Suppl.): 115-21
38. Fry RP, Crisp AH, Beard RW. Sociopsychological factors in chronic pelvic pain, a review. J Psychosom Res 1997 Jan; 42 (1): 1-15
39. Masters EH, Johnson VE. Human sexual response. Boston (MA): Little, Brown and Company, 1966
40. Kaplan HS. The new sex therapy. London: Bailliere Tindall, 1974
41. Basson R. Using a different model for female sexual response to address women's problematic low sexual desire. J Sex Marital Ther 2001 Oct-Dec; 27 (5): 395-403
42. Davison SL, Davis SR. Androgens in women. J Steroid Biochem Mol Biol 2003 Jun; 85 (2-5): 363-6
43. Burger HG. Androgen production in women. Fertil Steril 2002 Apr; 77 Suppl. 4: 3-5
44. Hutchison JB, Steimer TH. Preoptic formation of 17β oestradiol is influenced by behavioural stimuli in the dove. Brain Res 1985; 360: 366-9
45. Katz S, Morales AJ. Dehydroepiandrosterone (DHEA) and DHEA-sulphate (DHEAS) as therapeutic options in menopause. Semin Reprod Endocrinol 1998; 16: 161-70
46. Rako S. The hormone of desire: the truth about testosterone, sexuality and menopause. New York: Three Rivers Press, 1999
47. Sherwin BB, Gelfand MM. Differential symptom response to parental estrogen and androgen in the surgical menopause. Am J Obstet Gynecol 1985; 151: 153-60
48. Marin R, Escrig A, Abreu P, et al. Androgen-dependent nitric oxide release in rat penis correlates with levels of constitutive nitric oxide synthase isoenzymes. Biol Reprod 1999; 61: 1012-6
49. Rittmaster RS. Clinical relevance of testosterone and dihydrotestosterone metabolism in women. Am J Med 1995; 98 Suppl. IA: 17-21
50. Burger HG, Dudley EC, Hopper JL, et al. The endocrinology of menopausal transition: a cross-sectional study of population-based sample. J Clin Endocrinol Metab 1995; 80: 3537-47
51. Davis SR, Burger HG. Androgens and the postmenopausal woman. J Clin Endocrinol Metab 1996; 81: 2759-64
52. Simpson ER, Davis SR. Minireview: aromatase and the regulation of estrogen biosynthesis: some new perspectives. Endocrinology 2001 Nov; 142 (11): 4589-94
53. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy: sexual behavior and neuroendocrine response. J Reprod Med 1998 Oct; 43 (10): 847-56
54. Sarrel PM. Ovarian hormones and vaginal blood flow: using laser Doppler velocimetry to measure effects in a clinical trial of post-menopausal women. Int J Impot Res 1998; 10: S91-3
55. Caillouette JC, Sharp Jr CF, Zimmerman GJ, et al. Vaginal pH as a marker for bacterial pathogens and menopausal status. Am J Obstet Gynecol 1997; 176 (6): 1270-5
56. Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990; 75 Suppl. 4: 26-30S
57. Wyckoff MH, Chambliss KL, Mineo C, et al. Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i). J Biol Chem 2001; 276: 27071-6
58. Berman JR, McCarthy MM, Kyprianou N. Effect of estrogen withdrawal on nitric oxide synthase expression and apoptosis in the rat vagina. Urology 1998; 51: 650-6
59. Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am 1995; 22: 699-709
60. Kaiser FE, Korenman SG. Impotence in diabetic men. Am J Med 1988; 85: 147-52
61. Morley JE, Korenman SG, Kaiser FE, et al. Relationship of penile brachial pressure index to myocardial infarction and cerebrovascular accidents in older men. Am J Med 1988; 84: 445-8
62. Park K, Goldstein I, Andry C, et al. Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res 1997 Mar; 9 (1): 27-37
63. Goldstein I, Berman JR. Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes. Int J Impot Res 1998; 10 Suppl. 2: S84-90
64. Manonai J, Theppisai U, Suthutvoravut S, et al. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study. J Obstet Gynaecol Res 2001 Oct; 27 (5): 255-60
65. Robinson D, Cardozo LD. The role of estrogens in female lower urinary tract dysfunction. Urology 2003 Oct; 62 (4 Suppl. 1): 45-51
66. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985; 47: 339-51
67. Sipski ML, Alexander CJ, Rosen RC. Sexual response in women with spinal cord injuries: implications for our understanding of the able-bodied. J Sex Marital Ther 1999; 25: 11-22
68. Sipski ML. Sexual response in women with spinal cord injury: neurologic pathways and recommendations for the use of electrical stimulation. J Spinal Cord Med 2001; 24 (3): 155-8
69. Le Mone P. The physical effects of diabetes on sexuality in women. Diabetes Educ 1996; 22 (4): 361-6
70. Sarkadi A, Rosenqvist U. Contradictions in the medical encounter: female sexual dysfunction in primary care contacts. Fam Pract 2001; 18 (2): 161-6
71. Shafik A, El-Sibai O. Study of the pelvic floor muscels in vaginismus: a concept of pathogenesis. Eur J Obstet Gynecol Reprod Biol 2002 Oct 10; 105 (1): 67-70
72. Reissing ED, Binik YM, Khalife S, et al. Vaginal spasm, pain, and behavior: an empirical investigation of the diagnosis of vaginismus. Arch Sex Behav 2004 Feb; 33 (1): 5-17
73. Meston CM. The psychophysiological assessment of female sexual function. American Association of Sex Educators, Counselors, and Therapists, Inc. (AASECT). J Sex Educ Ther 2000; 25 (1): 6-16
74. Aksaray G, Yelken B, Kaptanoglu C, et al. Sexuality in women with obsessive compulsive disorder. J Sex Marital Ther 2001; 27 (3): 273-7
75. Clayton AH. Recognition and assessment of sexual dysfunction associated with depression. J Clin Psychiatry 2001; 62 Suppl. 3: 5-9
76. Woosley RL, Flockhart D. A case for the development of Centers for Education and Research in Therapeutics (CERT). Pharmacy Week 1995; 4 (23): 1-3
77. Finger WW, Lund M, Slagle MA. Medications that may contribute to sexual disorders: a guide to assessment and treatment in family practice. J Fam Pract 1997 Jan; 44 (1): 33-43
78. Shifren JL. The role of androgens in female sexual dysfunction. Mayo Clin Proc 2004 Apr; 79 (4 Suppl.): S19-24
79. Davis S. Testosterone deficiency in women. J Reprod Med 2001 Mar; 46 (3 Suppl.): 291-6
80. Collins A, Landgren BM. Reproductive health, use of estrogen and experience of symptoms in postmenopausal women: a population based study. Maturitas 1994; 20 (2): 101-11
81. Burkman RT, Collins JA, Greene RA. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol 2001 Aug; 185 2 Suppl.: S13-23
82. Wells G, Herrington DM. The Heart, and Estrogen/Progestin Replacement Study: what have we learned and what questions remain? Drugs Aging 1999 Dec; 15 (6): 419-22
83. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003 Aug 7; 349 (6): 523-34
84. Nelson HD, Humphrey LL, Nygren P, et al. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002 Aug 21; 288 (7): 872-81
85. Montgomery JC, Appleby L, Brincat M, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987; I: 297-9
86. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343: 682-8
87. Davis SR, Tran J. Testosterone influences libido and well being in women. Trends Endocrinol Metab 2001; 12: 33-7
88. Mazer NA. New clinical applications of transdermal testosterone delivery in men and women. J Control Release 2000; 65: 303-15
89. Berman LA, Berman JR, Chhabra S, et al. Novel approaches to female sexual dysfunction. Expert Opin Investig Drugs 2001 Jan; 10(1): 85-95
90. Rako S. Testosterone supplemental therapy after hysterectomy with or without concomitant oophorectomy: estrogen alone is not enough. J Womens Health Gend Based Med 2000; 9: 17-23
91. Basson R, McInnes R, Smith MD, et al. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med 2002 May; 11 (4): 367-77
92. Caruso S, Intelisano G, Lupo L, et al. Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. BJOG 2001 Jun; 108 (6): 623-8
93. Kaplan SA, Reis RB, Kohn IJ, et al. Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology 1999 Mar; 53 (3): 481-6
94. Basson R, Brotto LA. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial. BJOG 2003 Nov; 110 (11): 1014-24
95. Berman JR, Berman LA, Lin H, et al. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther 2001 Oct-Dec; 27 (5): 411-20
96. Sipski ML, Rosen RC, Alexander CJ, et al. Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury. Urology 2000 Jun; 55 (6): 812-5
97. Shen WW, Urosevich Z, Clayton DO. Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors. J Reprod Med 1999 Jun; 44 (6): 535-42
98. Hellstrom WJ. Vardenafil: a new approach to the treatment of erectile dysfunction. Curr Urol Rep 2003 Dec; 5 (6): 479-87
99. Angulo J, Cuevas P, Cuevas B, et al. Vardenafil enhances clitoral and vaginal blood flow responses to pelvic nerve stimulation in female dogs. Int J Impot Res 2003 Apr; 15 (2): 137-41
100. Bella AJ, Brock GB. Tadalafil in the treatment of erectile dysfunction. Curr Urol Rep 2003 Dec; 4 (6): 472-8
101. Becher EF, Bechara A, Casabe A. Clitoral hemodynamic changes after a topical application of alprostadil. J Sex Marital Ther 2001 Oct-Dec; 27 (5): 405-10
102. Padma-Nathan H, Brown C, Fendl J, et al. Efficacy and safety of topical alprostadil cream for the treatment of female sexual arousal disorder (FSAD): a double-blind, multicenter, randomized, and placebo-controlled clinical trial. J Sex Marital Ther 2003 Oct-Dec; 29 (5): 329-44
103. Hatzichristou DG, Apostolidis A, Tzortzis V, et al. Effects of oral phentolamine, taken before sleep, on nocturnal erectile activity: a double-blind, placebo-controlled, crossover study. Im J Impot Res 2001 Oct; 13 (5): 303-8
104. Lue T, Goldstein I, Traish A. Comparison of oral and intra-cavernosal vasoactive agents in penile erection. Int J Impot Res 2000 Mar; 12 Suppl. 1: S81-8
105. Rubio-Aurioles E, Lopez M, Lipezker M, et al. Phentolamine mesylate in postmenopausal women with female sexual arousal disorder: a psychophysiological study. J Sex Marital Ther 2002; 28 Suppl. 1: 205-15
106. Rosen RC, Phillips NA, Gendrano III NC, et al. Oral phentolamine and female sexual arousal disorder: a pilot study. J Sex Marital Ther 1999 Apr-Jun; 25 (2): 137-44
107. Margolis R, Leslie CH. Review of studies on a mixture of nux vomica, yohimbine and methyl testosterone in the treatment of impotence. Curr Ther Res Clin Exp 1966 May; 8 (5): 280-4
108. Morales A. Yohimbine in erectile dysfunction: would an orphan drug ever be properly assessed? World J Urol 2001 Aug; 19 (4): 251-5
109. Michelson D, Kociban K, Tamura R, et al. Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. J Psychiatr Res 2002 May-Jun; 36 (3): 147-52
110. Mantovani F, Patelli E, Colombo F, et al. Erectile dysfunction after non nerve-sparing radical pelvic surgery: therapeutical experience with sildenafil and L-arginine evaluated by buckling-test. Minerva Urol Nefrol 2001 Sep; 53 (3): 135-7
111. Chen J, Wollman Y, Chernichovsky T, et al. Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int 1999 Feb; 83 (3): 269-73
112. Ito TY, Trant AS, Polan ML. A double-blind placebo-controlled study of ArginMax, a nutritional supplement for enhancement of female sexual function. J Sex Marital Ther 2001 Oct-Dec; 27 (5): 541-9
113. Meston CM, Worcel M. The effects of L-arginine and yohimbine on sexual arousal in postmenopausal women with female sexual arousal disorder. International Academy of Sexual Research; 2000 Jun 21-24; Paris
114. Andersson KE. Neurophysiology/pharmacology of erection. Int J Impot Res 2001 Aug; 13 Suppl. 3: S8-17
115. Giuliano F, Allard J. Dopamine and male sexual function. Eur Urol 2001 Dec; 40 (6): 601-8
116. Molinoff PB, Shadiack AM, Earle D, et al. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci 2003 Jun; 994: 96-102
117. Gregorian RS, Golden KA, Bahce A, et al. Antidepressant-induced sexual dysfunction. Ann Pharmacother 2002 Oct; 36 (10): 1577-89
118. Borsini F, Evans K, Jason K, et al. Pharmacology of flibanserin. CNS Drug Rev 2002; 8 (2): 117-42
119. Negro-Vilar A. Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium. J Clin Endocrinol Metab 1999 Oct; 84 (10): 3459-62
120. Kearney CE, Purdie DW. Selective estrogen receptor modulators. Climacteric 1998 Jun; 1 (2): 143-7
121. Kloosterboer H. Tibolone: a steroid with tissue-specific mode of action. J Steroid Biochem Mol Biol 2001; 76: 231-8
122. Doren M, Rubig A, Coelingh Bennink HJ, et al. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. Fertil Steril 2001 Mar; 75 (3): 554-9
123. Palacios S, Menendez C, Jurado AR, et al. Changes in sex behaviour after menopause: effects of tibolone. Maturitas 1995 Sep; 22 (2): 155-61
124. Laan E, van Lunsen RH, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001 Mar; 4 (1): 28-41
125. Nathorst-Boos J, Hammar M. Effect on sexual life: a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen. Maturitas 1997 Jan; 26 (1): 15-20
126. Wilson SK, Delk II JR, Billups KL. Treating symptoms of female sexual arousal disorder with the EROS-clitoral therapy device. J Gend Specif Med 2001; 4 (2): 54-8